Dr. Kumar Saurav

Urology, Uro-oncology & Andrology

Dr Kumar Saurav is a Urologist and Andrologist working in New Delhi. He is an alumnus of the top educational institutes of India and is currently associated with the Sant Parmanand Hospital, MD City Hospital and Adarsh Multispeciality Hospital & Trauma Centre as Consultant Urologist.

He graduated (MBBS) from the prestigious Maulana Azad Medical College (MAMC) & Lok Nayak Hospital (LNH) in New Delhi, followed by Post-graduate training (MS General Surgery) from the premier institute of PGIMER, Chandigarh. He was selected for Super speciality training (MCh Urology) from the Department of Urology, Robotics & Renal Transplant at Vardhman Mahavir Medical College (VMMC) & Safdarjung Hospital (SJH), New Delhi, where his areas of interest included endo-urology, Uro-oncology, laparoscopic surgery, prostate and stone disease.

He has assisted and performed more than five hundred endoscopic, laparoscopic, robotic and open surgeries including TURP, TURBT, URSL, DJ Stent placement, PCNL, PCN placement, Botox injection, HOLEP (laser prostatectomy), Simple and Radical nephrectomy, Pyeloplasty, Radical Prostatectomy, Radical Cystectomy, Varicocelectomy, Orchidopexy, Orchidectomy, Penectomy, Urethroplasty, Dialysis Access and Circumcision etc.

He has special interest in management of Benign Prostatic enlargement, Kidney and ureter stones, Urological cancers, functional and neuro-urology, laparoscopic surgeries, infertility, Andrology and Sexual Wellness.

He is a firm believer in providing top notch medical care to his patients. Despite his busy clinical schedule, he keeps up with publishing medical research in national and international journals of repute to stay abreast with the latest development and to contribute his bit in the advancement of Urology.

Publications:

  • Pawan Vasudeva, Siddharth Yadav, Helmut Madersbacher, Niraj Kumar, Vishnu Prasad, Kumar Saurav, Ramesh Kumar, Diganta Borah.Efficacy and safety of mirabegron for the treatment of low compliance bladder resulting from sacral/infrasacral lesions: A prospective study. Int J Urol 2020; 27(6): 552-558.
  • Vasudeva P, Kumar N, Madersbacher H, Yadav S, Prasad V, Saurav K. Frequency volume chart for the illiterate population: A simple solution. Indian J Urol. 2019;35(4):278–281.
  • 3. Kumar N, Yadav S, Kumar S, Saurav K, Prasad V, Vasudeva P. Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml. Indian J Urol 2019;35:202-7.
  • 4. Kumar A, Gupta P, Kumar S, Yadav S, Prasanth YM, Tyagi V, Prasad V, Saurav K. 3-D transperitoneal laparascopic radical prostatectomy in locally advanced high-risk prostate cancer: a prospective evaluation. Cent European J Urol. 2019;72(2):218-219.
  • 5. Gupta P, Kumar S, Yadav S, Prasanth YM, Tyagi V, Prasad V, Saurav K. A prospective evaluation of the outcomes of 3-D transperitoneal laparoscopic vesico-vaginal fistula repair with omental interposition: our experience. Cent European J Urol. 2019;72(2):217.
  • 6. Gupta P, Kumar S, Yadav S, Prasanth YM, Tyagi V, Prasad V, Saurav K. ‘No clamp’ – Zero Ischemia time 3-D Laparoscopic transperitoneal partial nephrectomy: a prospective evaluation. Cent European J Urol. 2019;72(2):216.
  • 7. Kumar A, Gupta P, Kumar S, Yadav S, Prasanth YM, Tyagi V, Prasad V, Saurav K. A prospective evaluation of donor and graft outcomes of 3-D laparoscopic donor nephrectomy: a single centre experience. Cent European J Urol. 2019;72(1):72.
  • 8. Kumar A, Gupta P, Kumar S, Yadav S, Prasanth YM, Tyagi V, Prasad V, Saurav K. 3-D laparoscopic ureteric reimplantation with Boari Flap for long segment ureteric strictures secondary to genito-urinary tuberculosis: our experience. Cent European J Urol. 2019;72(1):71.
  • 9. Vishnu Prasad, Siddharth Yadav, Pawan Vasudeva, Kumar Saurav, Y. M. Prashanth, Vijay Tyagi. Efficacy and safety of mirabegron for the treatment of low compliant acontractile/underactive detrusor due to conus/cauda/peripheral nerve lesions: A prospective study. Abstracts – USICON 2020. Indian J Urol 2020;36, Suppl S1:1-56
  • 10. K. Saurav, U. Agrawal, P. Vasudeva, Y. M. Prashanth, V. Prasad, V. Tyagi. Expression of syndecan-1 in urothelial bladder cancer: A novel marker for prognosis and targeted therapy. Abstracts – USICON 2020. Indian J Urol 2020;36, Suppl S1:1-56
  • 11. V. Tyagi, M. Patel, P. Vasudeva, Y. M. Prashanth, V. Prasad, K. Saurav. To evaluate the impact of different catheter size on the urodynamic parameters and its clinical implication. Abstracts – USICON 2020. Indian J Urol 2020;36, Suppl S1:1-56